We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
These leaflets, in English, French, Bengali and Urdu, can help healthcare professionals speak with people about sickle cell disease.
This guidance explains PHE Screening’s consistent approach to standards across all 11 NHS screening programmes.
Guidance to support the health system to reduce inequalities in screening.
Role and remit of NHS population screening programmes’ Research, Innovation and Development Advisory Committee
Information to help healthcare professionals speak with parents at risk of having a child with sickle cell disease.
This document sets out for the programme specific operating model (PSOM) for quality assurance of the NHS antenatal and newborn (ANNB) screening programmes.
Information for pregnant women to understand what it means to be a sickle cell carrier.
Requirements for the quality assurance of laboratories providing antenatal and newborn screening services by the United Kingdom Accreditation Service (UKAS).
An overview of the sickle cell and thalassaemia (SCT) screening end-to-end pathway.
This document describes the sickle cell and thalassamia (SCT) screening pathways.
Information for pregnant women to understand what it means to be a delta beta thalassaemia.
Information and resources for health professionals who provide counselling for people at risk of having a baby with sickle cell disease or thalassaemia.
Information for pregnant women to understand what it means to be an alpha zero thalassaemia carrier.
Statutory guidance to help health professionals provide an inclusive screening programme to all eligible people.
Information for commissioners and screening providers, to help improve access to screening for people with severe mental illness.
This document sets out guidance for commissioning care services for people with sickle cell disease, thalassaemia and other haemoglobin conditions.
Advice for people who commission, fund, deliver and evaluate health outreach programmes.
Information to help healthcare professionals speak with parents at risk of having a child with thalassaemia.
This document sets out the guidelines for offering DNA tests, for babies who received a blood transfusion prior to their newborn blood spot screen.
Template letter for maternity trusts to use for sending screening results to women who miscarry or choose to end their pregnancy.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).